Sugi Predict

Sugi Predict / Compounds / Tetradecane

Tetradecane

Tetradecane

SCHEMBL2761407

CCCCCCCCCCCCCC.NC(CCCCCO)OS(=O)(=O)O

nearest known ligand 0.49

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TP53 P04637 2/20 0.49
▸ LMNA P02545 4/20 0.43
▸ ALDH1A1 P00352 1/20 0.43
▸ HSD17B10 Q99714 1/20 0.43
▸ MEN1 O00255 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ TSHR P16473 1/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ SPHK1 Q9NYA1 3/20 0.40
▸ CYP2D6 P10635 2/20 0.40
▸ LAP3 P28838 2/20 0.40
▸ GMNN O75496 1/20 0.40
▸ POLB P06746 1/20 0.40
▸ THPO P40225 1/20 0.40
▸ MTOR P42345 1/20 0.40
▸ BLM P54132 1/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ CYP1A2 P05177 1/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ MAPT P10636 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10766852 0.93 TP53 (0.55) TP53LMNASPHK1CYP2D6LAP3
SCHEMBL6763149 0.93 TP53 (0.55) TP53LMNASPHK1CYP2D6LAP3
SCHEMBL10782774 0.93 TP53 (0.55) TP53LMNASPHK1CYP2D6LAP3
SCHEMBL9439677 0.93 TP53 (0.55) TP53LMNASPHK1CYP2D6LAP3
SCHEMBL28829385 0.93 TP53 (0.55) TP53LMNASPHK1CYP2D6LAP3
SCHEMBL10777854 0.91 TP53 (0.57) TP53LMNASPHK1CYP2D6LAP3
SCHEMBL9452127 0.83 LMNA (0.46) TP53LMNAALDH1A1HSD17B10MEN1
SCHEMBL10683654 0.80 TP53 (0.49) TP53LMNAALDH1A1HSD17B10MEN1
Tetradecane SCHEMBL4197990 0.79 TP53 (0.46) TP53SPHK1LAP3S1PR2S1PR1
SCHEMBL10812506 0.78 TP53 (0.48) TP53SPHK1LAP3GRIK1GRIK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 136 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190099342-A1 COOLING PRODUCT SYMRISE AG (DE) 2019-04-04 — — US claimed
US-20240237643-A1 COMPOSITIONS WITH VIRUCIDAL AND/OR ANTIVIRAL ACTIVITY SYMRISE AG (DE) 2024-07-18 — — US disclosed
US-20240216248-A1 MICROBIAL GLYCOLIPIDS ANALYTICON DISCOVERY GMBH (DE) 2024-07-04 — — US disclosed
EP-4387587-A1 COMPOSITIONS Symrise AG (DE) 2024-06-26 — — EP disclosed
WO-2024110515-A1 AN ACTIVE COMPOSITION COMPRISING RETINOL SYMRISE AG (DE) 2024-05-30 — — WO disclosed
US-20240173227-A1 A FRAGRANCE MIXTURE CONTAINING ISOCITRONELLOL SYMRISE AG (DE) 2024-05-30 — — US disclosed
WO-2024104625-A1 A BLEND OF EMOLLIENTS SYMRISE AG (DE) 2024-05-23 — — WO disclosed
WO-2024104546-A1 A BLEND OF EMOLLIENTS SYMRISE AG (DE) 2024-05-23 — — WO disclosed
US-20240124808-A1 POLYUREA MICROCAPSULES AND LIQUID SURFACTANT SYSTEMS CONTAINING THEM SYMRISE AG (DE) 2024-04-18 — — US disclosed
US-20240122816-A1 ARTICLES FOR INDIRECT TRANSFER OF COSMETIC ACTIVES TO SKIN SYMRISE AG (DE) 2024-04-18 — — US disclosed
US-9144434-B1 Methods and compositions for treating skin RODAN & FIELDS, LLC (US) 2015-09-29 — — US disclosed
EP-2694834-A2 KERATIN-BASED HAIR STRAIGHTENING FORMULATIONS, METHODS AND SYSTEMS Baum, Marc Michael (US) 2014-02-12 — — EP disclosed
US-20130202543-A1 USE OF POLYOLS FOR ENHANCING THE COOLING EFFECT OF A COOLING SUBSTANCE AND COOLING MIXTURES HAVING AN ENHANCED COOLING EFFECT SYMRISE AG (DE) 2013-08-08 — — US disclosed
EP-2579950-A2 USE OF POLYOLS FOR ENHANCING THE COOLING EFFECT OF A COOLING SUBSTANCE AND COOLING MIXTURES HAVING AN ENHANCED COOLING EFFECT Symrise AG (DE) 2013-04-17 — — EP disclosed
US-8414872-B2 Hair straightening formulations, methods and systems LIQUID KERATIN, INC. (CA) 2013-04-09 — — US disclosed
WO-2012122457-A2 KERATIN-BASED HAIR STRAIGHTENING FORMULATIONS, METHODS AND SYSTEMS BAUM MARC MICHAEL (US) 2012-09-13 — — WO disclosed
WO-2010149798-A2 USE OF POLYOLS FOR ENHANCING THE COOLING EFFECT OF A COOLING SUBSTANCE AND COOLING MIXTURES HAVING AN ENHANCED COOLING EFFECT SYMRISE AG (DE) 2010-12-29 — — WO disclosed
EP-2200563-A1 HAIR STRAIGHTENING FORMULATIONS, METHODS AND SYSTEMS Resnick, Lionel (US) 2010-06-30 — — EP disclosed
US-20090165812-A1 HAIR STRAIGHTENING FORMULATIONS, METHODS AND SYSTEMS LIQUID KERATIN, INC. (CA) 2009-07-02 — — US disclosed
WO-2009035970-A1 HAIR STRAIGHTENING FORMULATIONS, METHODS AND SYSTEMS RESNICK LIONEL (US) 2009-03-19 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190099342-A1 COOLING PRODUCT TRPA1, TRPV2, NISCH TP53 1327/4885LMNA 2013/4885ALDH1A1 40/4885
US-20240216248-A1 MICROBIAL GLYCOLIPIDS UGCG, SGMS1, GPR119 TP53 3758/4885LMNA 4411/4885ALDH1A1 1617/4885
US-20240122816-A1 ARTICLES FOR INDIRECT TRANSFER OF COSMETIC ACTIVES TO SKIN CUTA, POLR1C, SLC16A7 TP53 4355/4885LMNA 2718/4885ALDH1A1 938/4885
US-20240237643-A1 COMPOSITIONS WITH VIRUCIDAL AND/OR ANTIVIRAL ACTIVITY ZC3HAV1, SAMHD1, ZC3HAV1L TP53 496/4885LMNA 2563/4885ALDH1A1 1969/4885
US-20130202543-A1 USE OF POLYOLS FOR ENHANCING THE COOLING EFFECT OF A COOLING SUBSTANCE AND COOLING MIXTURES HAVING AN ENHANCED COOLING EFFECT CUTA, MCOLN2, MCOLN3 TP53 4053/4885LMNA 893/4885ALDH1A1 1673/4885
US-20240173227-A1 A FRAGRANCE MIXTURE CONTAINING ISOCITRONELLOL IPO5, OR51E2, FDFT1 TP53 775/4885LMNA 3949/4885ALDH1A1 366/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.